8:45am ET
Investing
Huge Insider Buying in MGM and Salesforce
As the year winds down, insiders make huge buys in MGM Resorts and Salesforce. However, those were not the only notable instances of insider buying seen recently.
Companies
/Healthcare
Crescent Biopharma, Inc.
$18.02
â–² $1.02 (+6.00%) today
Markets closed · 11:57pm ET
Today · % change
Fundamentals
Market Cap
$631.4M
Revenue (TTM)
$11.9M
EPS (TTM)
$-0.14
52-Week Range
$9 – $27
Street Target
$30.60
About Glycomimetics
Crescent Biopharma, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, dedicated to developing innovative protease therapeutics that target hemostasis and complement regulation. The company is poised to address significant unmet medical needs through its promising pipeline, which includes novel candidates designed to tackle serious conditions associated with blood coagulation and immune response. Leveraging advanced research and proprietary technologies, Crescent Biopharma aims to deliver transformative solutions within the biopharmaceutical sector, positioning itself as a key player in the evolving landscape of therapeutic advancements.
